---
$id: https://graph.org.ai/products/commodity/51142533
$type: Product
source: UNSPSC
code: "51142533"
title: "Memantine"
class: "51142500"
classTitle: "Antiparkinson drugs"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Memantine

**UNSPSC Code**: 51142533
**Class**: [Antiparkinson drugs](Antiparkinson drugs.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a neuroprotective agent and antiparkinsonian agent with the molecular formula C12H21N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W8O17SJF3T, chemically known as 3,5-dimethyltricyclo(3.3.1.1(3,7))decan-1-amine but generally known as memantine, which bears US NIH Compound Identifier 4054. European Medicines Agency schedules Memantine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08731MIG. The term MEMANTINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 30, No. 10 1976, List 16). World Health Organization schedules memantine in its Anatomical Therapeutic Chemical (ATC) Classification. MEMANTINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule memantine under HS 29213099 and SITC 51453. As of Q4 2014, MEMANTINE remains the US FDA Preferred Term for this commodity. Memantine bears US NLM identifiers UMLS ID C0025242 and NCI Concept Code C73269. SMILES: NC12CC3(CC(C1)(CC(C3)C2)C)C.

